WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009064838) AQUEOUS FORMULATION OF ERYTHROPOIESIS STIMULATING PROTEIN STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/064838    International Application No.:    PCT/US2008/083327
Publication Date: 22.05.2009 International Filing Date: 13.11.2008
IPC:
A61K 9/00 (2006.01), A61K 38/18 (2006.01), A61K 38/19 (2006.01), A61K 39/395 (2006.01)
Applicants: AMGEN, INC. [US/US]; Patent Operation, M/s 28-2-c, One Amgen Center Drive, Thousand Oaks, CA 91320-1799 (US) (For All Designated States Except US).
SLOEY, Christopher, James [US/US]; (US) (For US Only).
KO, Jason [US/US]; (US) (For US Only).
LI, Tiansheng [US/US]; (US) (For US Only)
Inventors: SLOEY, Christopher, James; (US).
KO, Jason; (US).
LI, Tiansheng; (US)
Agent: HONG, Julie, J.; Marshall, Gerstein & Borun LLP, 233 S. Wacker Drive, Suite 6300, Sears Tower, Chicago, IL 60606-6357 (US)
Priority Data:
60/988,354 15.11.2007 US
Title (EN) AQUEOUS FORMULATION OF ERYTHROPOIESIS STIMULATING PROTEIN STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION
(FR) PRÉPARATION AQUEUSE DE PROTÉINE DE STIMULATION DE L'ÉRYTHROPOÏÈSE STABILISÉE PAR DES ANTIOXYDANTS POUR UNE ADMINISTRATION PAR VOIE PARENTÉRALE
Abstract: front page image
(EN)The present invention relates to stable aqueous protein formulations comprising an erythropoiesis stimulating protein and a stabilizing concentration of an antioxidant. In particular, disclosed herein are therapeutic protein formulations suitable for parenteral administration having one or more antioxidants.
(FR)L'invention concerne des préparations aqueuses stables de protéines comprenant une protéine de stimulation de l'érythropoïèse et une concentration en antioxydant stabilisante. L'invention concerne en particulier des préparations thérapeutiques de protéines contenant au moins un antioxydant, pouvant être administrées par voie parentérale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)